Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 11, 2005, Pages 4164-4169

  Hains, Bryan C ^b   Waxman, Stephen G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN; SODIUM CHANNEL BLOCKING AGENT; VOLTAGE GATED SODIUM CHANNEL; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; ANIMAL; CELL COUNT; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECT; NERVE FIBER; OPTIC NERVE; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; PATHOLOGY; RETINA GANGLION CELL; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; AXONS; CELL COUNT; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; NEUROPROTECTIVE AGENTS; OPTIC NERVE; OPTIC NERVE DISEASES; PHENYTOIN; RATS; RATS, WISTAR; RETINAL GANGLION CELLS; SODIUM CHANNEL BLOCKERS;

EID: 33644674443     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0618     Document Type: Article

References (36)

1. 2+ exchanger. J Neurosci. 1992;2:430-439.
2. + conductance in rat optic nerve axons. Proc Natl Acad Sci USA. 1993;90:6976-6980.
3. Stys PK, Ransom BR, Waxman SG. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol. 1992;67:236-240.
4. + current of mammalian CNS neurones. Neuroreport. 1995;6:1778-1780.
5. Segal MM, Douglas AF. Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J Neurophysiol. 1997;77:3021-3034.
6. Fern R, Ransom BR, Stys PK, Waxman SG. Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J Pharmacol Exp Ther. 1993;266:1549-1555.
7. Lo AC, Black JA, Waxman SG. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport. 2002;13:1909-1912.
8. Lo AC, Saab CY, Black JA, Waxman SG. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol. 2003;90:3566-3571.
9. Naskar R, Quinto K, Romann I, Schuettauf F, Zurakowski D. Phenytoin blocks retinal ganglion cell death after partial optic nerve crush. Exp Eye Res. 2002;74:747-752.
10. Hains BC, Saab CY, Lo AC, Waxman SG. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI. Exp Neurol. 2004;188:365-377.
11. Pinus MR, Abraham NZ. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia: WB Saunders; 1991.
12. Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res. 1995;61:379-382.
13. Sawada A, Neufeld AH. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res. 1999;69:525-531.
14. Mittag TW, Danias J, Pohorenec G, et al. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2000;41:3451-3459.
15. Selles-Navarro I, Villegas-Perez MP, Salvador-Silva M, Ruiz-Gomez JM, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:2002-2014.
16. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York: Academic Press; 1986.
17. Wang X, Tay S, Ng Y-K. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp Brain Res. 2000;132:476-484.
18. Sloan KE, Stevenson JA. Differential distribution of phosphorylated and non-phosphorylated neurofilaments within the retina and optic nerve of hamsters. Brain Res. 1987;437:365-368.
19. Williams RW, Strom RC, Rice DS, Goldowitz D. Genetic and environmental control of variation in retinal ganglion cell number in mice. J Neurosci. 1996;16:7193-7205.
20. Kanamori A, Nakamura M, Nakanishi Y, et al. Akt is activated via insulin/IGF-1 receptor in rat retina with episcleral vein cauterization. Brain Res. 2004;1022:195-204.
21. Ko ML, Hu DN, Ritch R, Sharma SC, Chen CF. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett. 2001;305:139-142.
22. Wolf HK, Buslei R, Schmidt-Kastner R, et al. NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem. 1996;44:1167-1171.
23. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
24. Johnson EC, Deppmeier LM, Wentzien SK, Hsu I, Morrison JC. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci. 2000;41:431-442.
25. Chauhan BC, Pan J, Archibald ML, LeVatte TL, Kelly ME, Tremblay F. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest Ophthalmol Vis Sci. 2002;43:2969-2976.
26. Maeda K, Sawada A, Matsubara M, Nakai Y, Hara A, Yamamoto T. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat. Invest Ophthalmol Vis Sci. 2004;45:851-856.
27. Laquis S, Chaudhary P, Sharma SC. The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res. 1998;784:100-104.
28. v1.7 sodium channels in mouse spinal sensory neurons. J Physiol. 2003;551:741-750.
29. v1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc Natl Acad Sci USA. 2000;97:5616-5620.
30. v1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain. 2004;127:294-303.
31. MacDonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia. 1993;34:S1-S8.
32. MacDonald RL, McLean MJ. Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia. 1982;23:S7-S18.
33. Ragsdale DS, Avoll M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res Rev. 1998;26:16-28.
34. Becker B, Stamper RL, Asseff C, Podos SM. Effect of diphenylhydantoin on glaucomatous field loss: a preliminary report. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:412-422.
35. Keltner JL, Becker B, Gay AJ, Podos SM. Effect of diphenylhydantoin in ischemic optic neuritis. Trans Am Ophthalmol Soc. 1972;70:113-130.
36. Ellenberger C, Burde RM, Keltner JL. Acute optic neuropathy. Treatment with diphenylhydantoin. Arch Ophthalmol. 1974;91:435-438.